跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZOTREN 8 ondansetron (as hydrochloride dihydrate) 8mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ZOTREN 8 ondansetron (as hydrochloride dihydrate) 8mg tablet blister pack
Approved
STANDARD
ZOTREN 8 ondansetron (as hydrochloride dihydrate) 8mg tablet blister pack
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
bd66c6f4c559728f
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
bd66c6f4c559728f
Product Name
ZOTREN 8 ondansetron (as hydrochloride dihydrate) 8mg tablet blister pack
Artg Id
287602
Artg Name
ZOTREN 8 ondansetron (as hydrochloride dihydrate) 8mg tablet blister pack
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2017-10-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/a13366b07349eed6026d208977a5c3b4.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ec43ff489b5153cdf19e275b0ad289ac.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
bd66c6f4c559728f
Type
Standard
Back to TGA Approvals